LAZZARI, ELISA
LAZZARI, ELISA
Dipartimento di Scienze della Salute
ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies
2016 E. Lazzari, L. Crews, C. Wu, H. Leu, S. Ali, R. Chiaramonte, M. Minden, C. Costello, C.H.M. Jamieson
AKT promotes the oncogenic Notch signaling in T-cell acute lymphoblastic leukemia
2014 N. Platonova, L. Mirandola, E. Vigolo, G. Cermisoni, D. De Simone, S. Garavelli, E. Lazzari, M. Colombo, A. Neri, R. Chiaramonte
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia
2015 N. Platonova, E. Vigolo, G. Cermisoni, D. De Simone, M. Colombo, S. Garavelli, E. Lazzari, S. Galletti, A. Paoli, A. Neri, R. Chiaramonte
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
2017 E. Lazzari, P. Mondala, N. Santos, A. Miller, G. Pineda, Q. Jiang, H. Leu, S. Ali, A. Ganesan, C. Wu, C. Costello, M. Minden, R. Chiaramonte, A. Stewart, L. Crews, C. Jamieson
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1
2013 L. Mirandola, L. Apicella, M. Colombo, Y. Yuefei, D.G. Berta, N. Platonova, E. Lazzari, M. Lancellotti, G. Bulfamante, E. Cobos, M. Chiriva Internati, R. Chiaramonte
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, N. Platonova, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma
2014 S. Garavelli, E. Lazzari, M. Colombo, S. Ravaioli, N. Platonova, M. Lancellotti, L. Apicella, L. Mirandola, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Chemokine receptors as novel targets of the oncogene Notch1 in acute lymphoblastic leukemia
2013 L. Mirandola, M. Chiriva Internati, E. Cobos, Y. Yu, J.A. Figueroa, S. Garavelli, M. Colombo, E. Lazzari, N. Platonova, K. Zepeda, C.A. Jumper, M. Jenkins, R. Alalawi, V. Konala, A. Aulakh, S. Radhi, R. Chiaramonte
Generation of a stable fluorescent cell cycle reporter myeloma cell line for real-time evaluation of microenvironment-responsive and drug-induced cell cycle alterations
2014 E. Lazzari, L.A. Crews, C.N. Wu, H.S. Leu, R. Chiaramonte, C.H.M. Jamieson
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment
2017 M. Colombo, S. Galletti, S. Garavelli, R. Colella, F. Baccianti, N. Platonova, M. Palano, E. Lazzari, K. Thümmler, K. Todoerti, L.A. Crews, C.H.M. Jamieson, C. Goodyear, A. Neri, R. Chiaramonte
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma
2014 S. Garavelli, E. Lazzari, M. Colombo, S. Ravaioli, N. Platonova, M. Lancellotti, L. Apicella, L. Mirandola, S. Galetti, K. Todoerti, A. Neri, R. Chiaramonte
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model
2018 M. Colombo, M. Mazzola, R. Colella, S. Garavelli, M. Palano, M. Barbieri, E. Lazzari, D. Giannandrea, N. Platonova, A. Neri, A. Pistocchi, R. Chiaramonte
MECHANISMS OF DRUG-ESCAPE AND RELAPSE IN MULTIPLE MYELOMA: INTERPLAY BETWEEN ADAR1 AND NOTCH IN ABERRANT RNA EDITING
2015 E. Lazzari
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
2020 M. Colombo, S. Garavelli, M. Mazzola, N. Platonova, D. Giannandrea, R. Colella, L. Apicella, M. Lancellotti, E. Lesma, S. Ancona, M.T. Palano, M. Barbieri, E. Taiana, E. Lazzari, A. Basile, M. Turrini, A. Pistocchi, A. Neri, R. Chiaramonte
Multiple myeloma-associated drug resistance : targeting the Notch pathway
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, A. Moschini, N. Platonova, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
2016 M. Colombo, S. Galletti, G. Bulfamante, M. Falleni, D. Tosi, K. Todoerti, E. Lazzari, L.A. Crews, C.H.M. Jamieson, S. Ravaioli, F. Baccianti, S. Garavelli, N. Platonova, A. Neri, R. Chiaramonte
Notch receptors regulate multiple myeloma-driven osteoclastogenesis
2012 M. Colombo, L. Mirandola, N. Platonova, E. Lazzari, M. Lancellotti, L. Apicella, R. Chiaramonte
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, A. Moschini, N. Platonova, S. Galletti, K. Todoerti, A.L. Crews, H.M..C. Jamieson, A. Neri, R. Chiaramonte
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance
2016 S. Garavelli, E. Lazzari, M. Colombo, M.T. Palano, F. Baccianti, F. Farris, N. Platonova, S. Galletti, K. Todoerti, A.L. Crews, H.M..C. Jamieson, A. Neri, R. Chiaramonte
Notch signaling drives multiple myeloma induced osteoclastogenesis
2014 M. Colombo, K. Thümmler, L. Mirandola, S. Garavelli, K. Todoerti, L. Apicella, E. Lazzari, M. Lancellotti, N. Platonova, M. Akbar, M. Chiriva-Internati, R. Soutar, A. Neri, C.S. Goodyear, R. Chiaramonte